CORSICO, ANGELO GUIDO
 Distribuzione geografica
Continente #
NA - Nord America 9.715
AS - Asia 6.926
EU - Europa 5.070
SA - Sud America 1.138
Continente sconosciuto - Info sul continente non disponibili 270
AF - Africa 265
OC - Oceania 13
Totale 23.397
Nazione #
US - Stati Uniti d'America 9.454
CN - Cina 2.896
SG - Singapore 1.711
IE - Irlanda 954
BR - Brasile 836
IT - Italia 756
HK - Hong Kong 752
VN - Vietnam 737
DE - Germania 598
RU - Federazione Russa 582
UA - Ucraina 504
FI - Finlandia 475
FR - Francia 399
GB - Regno Unito 270
SE - Svezia 205
IN - India 184
BD - Bangladesh 173
ZA - Sudafrica 155
CA - Canada 123
AR - Argentina 103
MX - Messico 72
IQ - Iraq 67
PL - Polonia 61
JP - Giappone 59
EC - Ecuador 54
NL - Olanda 53
CO - Colombia 50
TR - Turchia 38
ID - Indonesia 37
AT - Austria 35
ES - Italia 35
SA - Arabia Saudita 35
BE - Belgio 34
PH - Filippine 34
PK - Pakistan 33
VE - Venezuela 28
CL - Cile 24
MA - Marocco 23
CZ - Repubblica Ceca 20
UZ - Uzbekistan 20
TN - Tunisia 18
LT - Lituania 17
PY - Paraguay 17
JO - Giordania 16
IL - Israele 13
JM - Giamaica 13
KE - Kenya 13
AZ - Azerbaigian 12
EG - Egitto 12
MY - Malesia 12
AE - Emirati Arabi Uniti 11
DZ - Algeria 11
NP - Nepal 11
HN - Honduras 10
KZ - Kazakistan 10
PE - Perù 10
AU - Australia 9
CH - Svizzera 9
CR - Costa Rica 9
ET - Etiopia 9
OM - Oman 9
PS - Palestinian Territory 9
RO - Romania 8
UY - Uruguay 8
LB - Libano 7
MU - Mauritius 7
SK - Slovacchia (Repubblica Slovacca) 7
BO - Bolivia 6
TH - Thailandia 6
AL - Albania 5
BY - Bielorussia 5
DK - Danimarca 5
HU - Ungheria 5
KW - Kuwait 5
PA - Panama 5
PT - Portogallo 5
GR - Grecia 4
NI - Nicaragua 4
PR - Porto Rico 4
TT - Trinidad e Tobago 4
BB - Barbados 3
BG - Bulgaria 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
IR - Iran 3
KH - Cambogia 3
LK - Sri Lanka 3
MK - Macedonia 3
MN - Mongolia 3
NZ - Nuova Zelanda 3
AM - Armenia 2
AO - Angola 2
BW - Botswana 2
CI - Costa d'Avorio 2
EU - Europa 2
GY - Guiana 2
HR - Croazia 2
KG - Kirghizistan 2
MM - Myanmar 2
NG - Nigeria 2
Totale 23.089
Città #
San Jose 1.097
Dublin 953
Chandler 951
Singapore 920
Ashburn 813
Hong Kong 729
Dallas 665
Jacksonville 612
Nanjing 564
Beijing 510
Council Bluffs 482
Boardman 314
Ho Chi Minh City 262
Los Angeles 241
Nanchang 228
Lauterbourg 217
Hanoi 188
Princeton 186
Lawrence 181
Wilmington 175
Munich 171
New York 170
Milan 161
Shenyang 161
Changsha 151
Helsinki 144
Johannesburg 138
Ann Arbor 137
Jiaxing 119
Hebei 114
Medford 111
Moscow 111
Redondo Beach 108
Santa Clara 104
Tianjin 99
Buffalo 94
Shanghai 92
Turku 86
Hangzhou 85
Orem 77
Pavia 76
Woodbridge 66
São Paulo 63
Dearborn 62
Warsaw 56
Tokyo 54
Columbus 47
Frankfurt am Main 47
Nuremberg 46
Verona 46
Denver 45
Atlanta 44
Houston 44
Phoenix 43
Rome 43
Chennai 42
Chicago 42
Seattle 41
London 40
Montreal 40
Toronto 39
Da Nang 38
Brooklyn 37
The Dalles 36
Norwalk 35
Brussels 33
San Francisco 30
Boston 27
Haiphong 27
Mexico City 27
Rio de Janeiro 27
Falls Church 26
Guangzhou 26
Amsterdam 25
Kunming 25
Falkenstein 24
Pune 24
Baghdad 23
Washington 23
Stockholm 22
Brasília 21
Curitiba 20
Biên Hòa 19
Des Moines 18
Fairfield 18
Guayaquil 18
Poplar 18
Tashkent 18
Mumbai 17
Paris 17
Turin 17
Chongqing 16
Florence 16
Jeddah 16
Jinan 16
Manchester 16
Mulazzano 16
Tappahannock 16
Vienna 16
Amman 15
Totale 14.626
Nome #
An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages. 212
Serum Aspergillus-specific IgE, IgG and IgG4 immunoglobulins assessment in the work-up of invasive pulmonary aspergillosis: a prospective cohort study 190
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 184
Temporal trend in the prevalence of asthma-like symptoms among young adults of Northern Italy. Results of European Community Respiratory Health Survey (ECRHS) – ITALY 2000 165
Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy 165
Persistent exercise limitation after successful pulmonary endoarterectomy: frequency and determinants 164
Test di provocazione bronchiale con metacolina (TPBM). Riflessioni sulle linee guida ATS 1999 – confronti con le linee guida ERS 1993. 158
Correction to: Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy (Internal and Emergency Medicine, (2020), 15, 8, (1457-1465), 10.1007/s11739-020-02493-y) 158
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 153
Asthma control in Europe: a real-world evaluation based on an international population-based study 149
Adipose Mesenchymal Extracellular Vesicles as Alpha-1-Antitrypsin Physiological Delivery Systems for Lung Regeneration 147
Chronic cough and phlegm in young adults 146
Allergen-specific immunoglobulin E and allergic rhinitis severity 146
Lyosecretome for use in the treatment of autoimmune diseases 144
"Nonobstructive" emphysema of the lung 143
Antihistamines in children and adolescents: A practical update 143
ADRB2 Gly16Arg polymorphism, asthma control and lung function decline. 141
Assessment and management of pulmonary alveolar proteinosis in a reference center. 141
Nutritional parameters associated with prognosis in non-critically ill hospitalized COVID-19 patients: The NUTRI-COVID19 study 141
Lyosecretome for use in the treatment or prevention of skin aging by inhibiting elastase and tyrosinase activity 140
Bronchial responsiveness to ultrasonic fog in occupational asthma due to toluene diisocyanate 138
Are the asthma guideline goals achieved in daily practice? A population-based study on treatment adequacy and the control of asthma 138
Changes in IgE sensitization and total IgE levels over 20 years of follow-up 138
Lyosecretome for use in the treatment of degenerative osteoarticular diseases and/or degenerative intervertebral disc disease. 138
Allergic rhinitis and asthma comorbidity in a survey of young adults in Italy. 137
Aerosol thermal therapy benefit in chronic bronchitis treatment. 136
Advances in Identifying Urine/Serum Biomarkers in Alpha-1 Antitrypsin Deficiency for More Personalized Future Treatment Strategies 136
Athletic protocol in non-cystic fibrosis-related bronchiectasis: rationale and design of the pilot ATHOS study 134
Il test da sforzo cardiopolmonare (TCP) nello studio delle malattie respiratorie e in riabilitazione. Parte II. 134
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 134
Assessment of emphysema in COPD. A functional and radiologic study 132
Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome 132
Long-term effects of pulmonary andoarterectomy on cardioplmonary function and exercise tolerance 131
Lung bronchiectasisas a paradigm of the interplay between infection and colonization on plastic modulation of the pre-metastatic niche 130
Chronic productive cough in young adults is very often due to chronic rhino-sinusitis 130
Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy 130
The relationship between allergen immunotherapy and omalizumab for treating asthma 127
Exacerbations as a starting point of pro-active chronic obstructive pulmonary disease management. 125
Mechanisms for isolated volume response to a bronchodilator in patients with COPD 124
Longterm hemodynamic and functional results after pulmonary endarterectomy 124
COVID vaccination and asthma exacerbation: might there be a link? 121
Mesenchymal Extracellular Vesicles as Alpha-1-antitrypsin physiological delivery systems for lung regeneration 120
Long-term outcome after pulmonary endarterectomy. 119
Vitamin D 25OH deficiency in COVID-19 patients admitted to a tertiary referral hospital 119
Asthmatics and ex-smokers respond early, heavy smokers respond late to mailed surveys in Italy. 117
Changes in the use of anti-asthmatic medication in an international cohort. 115
Lyosecretome for use in the treatment of alpha-1-antitrypsin deficiency associated diseases 115
Pulmonary endarterectomy: the lancet first, tears for pills. 114
A three-generation study on the association of tobacco smoking with asthma 114
Asthma-like symptoms: Is it always a pulmonary issue? 114
Freeze-dried MSC-secretome contains active alpha-1-antitrypsin for treatment of deficiency pulmonary diseases 114
Serum Aspergillus-specific IgE, IgG and IgG4 immunoglobulins assessment in the work-up of Invasive Pulmonary Aspergillosis: a prospective cohort study 113
Il rapporto VEMS/CVF come cut-off fisso é un parametro accurato e affidabile per la diagnosi funzionale di ostruzione bronchiale nella BPCO: CON | [FEV1/FVC as a fixed cut-off is an accurate and reliable parameter for functional diagnosis of bronchial obstruction in COPD: CON] 113
International variations in asthma treatment compliance: the results of the European Community Respiratory Health Survey (ECRHS). 111
Pharmacological treatment of asthma in a cohort of adults during a 20-year period: results from the European Community Respiratory Health Survey I, II and III 111
Bacterial load and inflammatory response in sputum of alpha-1 antitrypsin deficiency patients with COPD 111
Pulmonary involvement in patients with Marfan Syndrome. 110
Absolute values of lung function explain the sex difference in breathlessness in the general population 110
Allergen-specific immunoglobulin E and allergic rhinitis severity 110
Effects of inhaled steroids on methacholine-induced bronchoconstriction and gas trapping in mild asthma. 109
Lung function in survivors of childhood acute lymphoblastic leukemia 108
Case-finding for alpha1-antitrypsin deficiency in Kazakh patients with COPD 108
The course of asthma during pregnancy in a recent, multicase-control study on respiratory health 108
Human health and air conditioning systems. 107
Asthma in childhood reduces smoking initiation in subsequent teenage among males. 107
Prevalence of allergic rhinitis in young adults in Italy 106
Underestimation of airflow obstruction among young adults using FEV1/FVC <70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes. 105
Comparison among populations with severe and intermediate alpha1-antitrypsin deficiency and chronic obstructive pulmonary disease 105
Eosinophilic cationic protein (ECP) in the clinical work-up of chronic cough 104
Il test da sforzo cardiopolmonare (TCP) nello studio delle malattie respiratorie e in riabilitazione. Parte I. 104
Linee guida per la misurazione ed interpretazione dei valori di ossigenazione arteriosa. 104
Late pulmonary sequelae after childhood bone marrow transplantation 103
The role of climate on the geographic variability of asthma, allergic rhinitis and respiratory symptoms: results from the Italian study of asthma in young adults. 103
The socio-economic burden of asthma is substantial in Europe. 103
Patients' interest in educational programmes on asthma. 102
Quality-of-life and asthma-severity in general population asthmatics: results of the ECRHS II study 102
Variations in the prevalence across countries of chronic bronchitis and smoking habits in young adults 101
Clinical features in patients with severe Alpha-1 antitrypsin deficiency due to rare genotypes 100
Lung cancer resection: the prediction of postsurgical outcomes should include long-term functional results. 100
Incidence of COPD in a Cohort of Young Adults According to the Presence of Chronic Cough and Phlegm. 100
SORVEGLIANZA DELLE MALATTIE BRONCOPOLMONARI CRONICO-OSTRUTTIVE NELLA POPOLAZIONE DI ROVESCALA (PAVIA) IN RELAZIONE ALL’ ESPOSIZIONE AL FUMO DI TABACCO 100
Freeze-dried MSC-secretome for use in the treatment of alpha-1-antitrypsin deficiency pulmonary diseases 100
Bioequivalence of inhaled formoterol fumarate assessed from pharmacodynamic, safety and urinary pharmacokinetic data. 99
Malignant Pleural Mesothelioma: From Pathophysiology to Innovative Actionable Targets 98
Mid term effects of pulmonary thromboendarterectomy on clinical and cardiopulmonary function status 98
MSC extracellular vesicles for treatment of alpha-1-antitrypsin deficiency pulmonary diseases 98
Eosinophilic cationic protein (ECP) in the clinical work-up of chronic cough 97
Occupational asthma caused by milk proteins: report on a case. 97
Local Therapies and Modulation of Tumor Surrounding Stroma in Malignant Pleural Mesothelioma: A Translational Approach 96
Asthma management in a specialist setting: Results of an Italian Respiratory Society survey 96
Sitagliptin treatment at the time of hospitalization was associated with reduced mortality in patients with type 2 diabetes and covid-19: A multicenter case-control retrospective observational study 96
A 28-Year-Old Man with Stridor and Dyspnea 96
Inadequate antiasthma drug use in the north of Italy. 95
Assessment of asthma severity in adults with ever asthma: A continuous score 95
Effects of exercise and beta 2-agonists on lung function in chronic obstructive pulmonary disease 94
Peak expiratory flow monitoring and airway response to specific bronchial provocation tests in asthmatics 94
Long-term clinical and cardiopulmonary effects of pulmonary endarteriectomy (PEA) 94
Prevalence of asthma-like symptoms with ageing 94
The Impact of Diagnosed and Undiagnosed Current Asthma in the General Adult Population 93
The Plastic Interplay between Lung Regeneration Phenomena and Fibrotic Evolution: Current Challenges and Novel Therapeutic Perspectives 92
Totale 12.060
Categoria #
all - tutte 100.069
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.069


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022767 0 0 23 7 26 33 34 41 55 23 137 388
2022/20232.791 341 144 27 278 230 284 7 180 1.151 21 82 46
2023/20241.079 118 203 47 65 118 238 51 85 10 48 30 66
2024/20253.719 70 223 102 149 94 322 186 238 867 194 397 877
2025/20269.599 654 690 993 1.196 1.070 401 1.837 448 913 654 427 316
2026/20271.033 388 551 94 0 0 0 0 0 0 0 0 0
Totale 23.397